Overview

Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the safety and efficacy of diosmin as adjuvant therapy in treatment of non-bleeding peptic ulcer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University